The booming Adeno-Associated Virus (AAV) CDMO market is projected to reach $0.57 billion by 2025, with a CAGR of 20.86% through 2033. Driven by cell & gene therapy advancements, this report analyzes market segments, key players (Thermo Fisher, Merck KGaA, Catalent), and regional trends. Learn more about this rapidly expanding industry.
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.